Onconetix, Inc.(ONCO)
Health Care Services
Lab Testing & Diagnostics
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-04-22 | HRT FINANCIAL LP 10% Owner | Sale | -49,710 | -59.63%33,649 | $0.69 | $34,300 | View SEC filing | |
| 2026-04-21 | HRT FINANCIAL LP 10% Owner | Mixed | -113,693 | -57.70%83,359 | $0.74 | $135,454 | View SEC filing | |
| 2026-04-16 | HRT FINANCIAL LP 10% Owner | Purchase | +166,904 | +553.62%197,052 | $0.76 | $127,591 | View SEC filing | |
| 2022-08-23 | Shaw Allan Director | Sale | -29,636 | -100.00%0 | $3.94 | $116,766 | View SEC filing | |
| 2022-08-22 | Hernandez Joseph CEO | Sale | -549,649 | -17.18%2,650,351 | $4.80 | $2,640,693 | View SEC filing | |
| 2022-08-22 | Henderson Erin Chief Business Officer | Sale | -4,834 | -16.34%24,752 | $3.97 | $19,191 | View SEC filing |
1-6 of 6